Drug Topics

OCTOBER 4, 2023

Digging deeper into the cause of insomnia and counseling patients on lifestyle changes can help improve their sleep health.

209

209

Pharmacy Times

OCTOBER 4, 2023

mRNA-1083 (Moderna) was found comparable to the standard dose of Fluarix (GSK) in adults aged 50 to 64 years and Fluzone HD ( Sanofi) for influenza and Spikevax (Moderna) for COVID-19.

Vaccines 149

Vaccines 149

Drug Topics

OCTOBER 4, 2023

Despite a wealth of data proving their efficacy for acute and chronic pain, these products remain underutilized in the United States.

201

201

Fierce Healthcare

OCTOBER 4, 2023

Nabla, maker of an autonomous clinical AI scribe, has joined forces with Kaiser Permanente to roll out its tool to 10,000 doctors in Northern California. | The AI tool will be available to 10,000 Kaiser Permanente doctors in Northern California across all care settings and specialties.

145

145

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharmacy Times

OCTOBER 4, 2023

An overview of antidepressant medications and their indications to inform health care professionals of their wide use and to better understand which antidepressant to recommend based on patient-specific characteristics.

132

132

STAT

OCTOBER 4, 2023

No medication is approved to treat addiction to either methamphetamine or cocaine. But the Food and Drug Administration is taking steps to fill that glaring gap in addiction medicine.  The agency on Wednesday issued draft guidance that encourages drug manufacturers to develop new treatments that could help treat addiction to meth, cocaine, or prescription stimulants.

FDA 137

FDA 137

STAT

OCTOBER 4, 2023

Physicians Alison Block and Nikki Zite knew what they were getting into when they became abortion providers early in their medical training. Family planning has long been a politicized, divisive area of medicine. And even though they knew that Roe v. Wade — the 1973 Supreme Court case that protected abortion access across the country — was being threatened, it still hit them hard when that ruling was actually overturned in June 2022.

131

131

Fierce Healthcare

OCTOBER 4, 2023

WellTheory, a platform focused on reducing autoimmune disease symptoms, has unveiled an enterprise product for employers and payers looking to offer autoimmune care. | The new offering aims to tackle the hidden costs and productivity impacts of untreated autoimmune diseases. It will include a community-based program that gives members access to events, tools, experts and peers for support.

129

129

STAT

OCTOBER 4, 2023

Amid the stunning rebuke Amgen suffered at the hands of the U.S. Food and Drug Administration this week lurk numerous questions. And one of them may be whether the company was fully forthcoming about a pricey lung cancer drug that is supposed to generate key revenue growth. At issue is a trial that Amgen is relying upon to win final approval for Lumakras, which the FDA approved on a conditional basis in 2021.

Documentation 129

Documentation FDA 129

Fierce Pharma

OCTOBER 4, 2023

Boehringer Ingelheim, which recently launched the first interchangeable biosimilar to AbbVie’s megablockbuster Humira, is getting in on the industry’s double-pricing trick. | After debuting its branded Humira biosim Cyltezo in July, Boehringer has launched an unbranded copycat of the inflammatory disease drug, simply called adalimumab-adbm injection, which will be sold at an 81% discount to Humira.

125

125

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

STAT

OCTOBER 4, 2023

The consumer watchdog group the Center for Science in the Public Interest filed a lawsuit against a diagnostics company called EpicGenetics on Wednesday, alleging that the company is making false and misleading claims in marketing its blood tests for fibromyalgia and other diseases. The lawsuit focuses on two tests marketed by EpicGenetics — the FM/a Test and the 100Sure Test — which the company describes using nearly identical language.

Insurance 127

Insurance Hospitals 127

The Checkup by Singlecare

OCTOBER 4, 2023

Managing your weight can be challenging, which is why many people look for relatively quick and easy ways to drop some pounds. That’s why you may have seen people talk about a medication called Vyvanse, which is FDA approved to treat ADHD and binge eating disorder, as a good option for weight loss. The reality, though, is that while weight loss can be a side effect of taking Vyvanse, the drug should not be used for the sole purpose of losing weight.

Labelling 125

Labelling FDA Controlled Substances Hospitals 125

STAT

OCTOBER 4, 2023

LONDON — The 2023 Nobel Prize in chemistry was awarded Wednesday to three scientists for the discovery and synthesis of quantum dots, tiny particles that have fueled innovations in nanotechnology from televisions to mapping different tissues in the body.   The prize went to Moungi Bawendi of MIT, Louis Brus of Columbia University, and Alexei Ekimov, formerly the chief scientist at Nanocrystals Technology in New York.

124

124

Pharmacy Times

OCTOBER 4, 2023

Hispanic individuals have been found to be more likely to develop complications as a result of diabetes compared to those who are non-Hispanic White.

130

130

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

STAT

OCTOBER 4, 2023

It’s the end of an era for a once-critical pandemic document: The ubiquitous white Covid-19 vaccination cards are being phased out. Now that Covid-19 vaccines are not being distributed by the federal government, the Centers for Disease Control and Prevention has stopped printing new cards.

Vaccines 123

Vaccines Documentation 123

Pharmacy Times

OCTOBER 4, 2023

The use of nirmatrelvir or molnupiravir can aid treatment for individuals that are at high risk of developing severe COVID-19, regardless of varying demographics.

123

123

Fierce Pharma

OCTOBER 4, 2023

After more than a year of preparation, Sandoz has officially parted ways with Swiss drug giant Novartis. But the company's day-one valuation lagged what some analysts had projected. | The generics and biosimilar maker debuted on the SIX Swiss Exchange at 24 Swiss francs ($26.16) for a total valuation of about $11.2 billion. Analysts had previously published ranges of $11 billion to $26 billion for the company, according to Reuters.

121

121

STAT

OCTOBER 4, 2023

An innocuous slip while cutting her toenails created a wound on Cynthia Elford’s right foot that wouldn’t heal. The Hermitage, Pennsylvania resident has vasculitis, a genetic disease that inflames the blood vessels and stops blood from flowing to the legs. She had already lost her left leg below the knee after a sunburn on the tip of her toe got progressively worse.

FDA 119

FDA 119

Pharmacy Times

OCTOBER 4, 2023

Laura Akers, PharmD, RPh/CPh, MBA, BCOP discusses the role of the pharmacist, how the pharmacy profession has changed, and what is to come in the field.

123

123

Fierce Pharma

OCTOBER 4, 2023

As long expected, the U.S. government is winding down its distribution of COVID-19 countermeasures. | The government will wind down its Lagevrio distribution ahead of the transition, the Administration for Strategic Preparedness and Response said.

118

118

STAT

OCTOBER 4, 2023

Nasal esketamine spray is more effective than an extended-release antipsychotic, when both are taken in combination with SSRIs and SNRIs, in patients with depressive episodes that didn’t respond to two or more consecutive treatments, according to a study published Wednesday in the New England Journal of Medicine. Research dating back to the early 2000s has shown that ketamine and esketamine — which is derived from ketamine — are effective in cases of so-called treatment-resi

116

116

Fierce Pharma

OCTOBER 4, 2023

After sparring with GSK’s ViiV Healthcare over the price of its HIV medication dolutegravir, Colombia appears to be taking matters into its own hands. | Colombian authorities say they plan to issue a compulsory license for ViiV Healthcare's dolutegravir, which goes by the name Tivicay on its own or as Dovato when combined with other therapeutics.

118

118

Fierce Healthcare

OCTOBER 4, 2023

Mental health provider Brightside Health is partnering with Centene, Optum, Lucet, Blue Cross and Blue Shield of Texas and other payers to serve 50 million people in Medicare and Medicaid. | Brightside Health announced expanded partnerships with major health payers including Centene, Optum and Lucet on Thursday.

117

117

Med Ed 101

OCTOBER 4, 2023

It’s hard to believe that I have been following pharmacist board certifications and helping pharmacists pass the BCPS exam for over 10 years since I first passed it in 2013! Each year in updating and creating our study materials, I review the content outline and any possible changes in the BCPS exam. There are definitely […] The post 2024 BCPS Exam – What’s Changing?

111

111

Fierce Healthcare

OCTOBER 4, 2023

More than half of therapists report experiencing burnout this year, a new survey has found. | At a time when Americans are increasingly seeking mental health treatment and there is a behavioral health workforce shortage, three-quarters of respondents who have experienced burnout say they are hesitant to take on more acute patients.

110

110

Fierce Pharma

OCTOBER 4, 2023

Lilly announced several C-Suite moves, including the retirement of Diabetes and Obesity chief Mike Mason, with his duties assumed by Patrick Jonsson.

121

121

Fierce Healthcare

OCTOBER 4, 2023

Minnesota Attorney General Keith Ellison announced Tuesday that he is reviewing two pending health system mergers under a recently passed state law that gave his office additional authority to dete | The Froedtert Health-ThedaCare and St. Luke's Duluth-Aspirus Health merger deals announced earlier this year will be subject to Minnesota Attorney General Keith Ellison's newly granted oversight authority.

110

110

STAT

OCTOBER 4, 2023

WASHINGTON — One of the top health care committees in the Senate is assembling ideas for bipartisan legislation to address drug shortages, three Senate aides and three lobbyists told STAT. The talks, led by Senate Finance Chair Ron Wyden (D-Ore.) and ranking member Mike Crapo (R-Idaho) are in the early days, but they could move the debate over drug shortage reforms into a new phase.

Hospitals 104

Hospitals Insurance 104

PharmaVoice

OCTOBER 4, 2023

The FDA wouldn’t review a drug that was 90% effective. In rare diseases, this is too common, said the UltraGenyx CEO and a leading rare disease researcher.

FDA 111

FDA 111

PharmExec

OCTOBER 4, 2023

In this Q&A with Pharmaceutical Executive®, Andrew Hopkins, founder and CEO of Exscientia, reveals how artificial intelligence (AI) is currently being utilized in the pharma industry, predictions for where AI can be implemented in the future, and what pharma fears most about AI.

105

105

pharmaphorum

OCTOBER 4, 2023

Novavax has been given the go-ahead by regulators in the US for an updated version of its COVID-19 vaccine that targets the XBB.1.5 variant of the coronavirus. The FDA has signed off on the new protein-based shot, which joins two XBB.1.5-directed mRNA-based vaccines from Pfizer/BioNTech and Moderna as options for the upcoming immunisation campaign in the US.

Vaccines 105

Vaccines FDA 105

Drug Topics

OCTOBER 4, 2023

In many industries, tipping is the norm. Pharmacists would just like to receive payment for services rendered.

112

112

European Pharmaceutical Review

OCTOBER 4, 2023

The World Health Organization ( WHO ) has recommended a new vaccine, R21/Matrix-M, to prevent malaria in children. The R21 vaccine is the second malaria vaccine recommended by WHO. This follows the WHO’s recommendation of the RTS,S/AS01 vaccine for the disease in 2021. Novavax’s President and Chief Executive Officer, John Jacobs, declared that the company is “proud” of the role of its saponin-based Matrix-M adjuvant plays in the R21/Matrix-M malaria vaccine.

Vaccines 105

Vaccines 105

Fierce Pharma

OCTOBER 4, 2023

The Federal Trade Commission (FTC) recently came up short in its attempt to derai | More than 30 companies and biopharma associations have introduced the Partnership for the US Life Science Ecosystem (PULSE) to increase awareness of the value of M&A. After successfully defending itself against the FTC lawsuit, Amgen is among the drugmakers who have signed on.

105

105